RecallDepth
Class II Terminated

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.

Company
Tris Pharma Inc.
Recall Initiated
July 11, 2019
Posted
July 31, 2019
Recall Number
D-1517-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,550 bottles
Firm Location
Monmouth Junction, NJ, United States

Reason for Recall

Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot#: 14079, Exp 10/2021

More recalls by Tris Pharma Inc.

View all recalls by this company →

Other recent Class II Drug recalls